Moderna Inc. MRNA was launched in 2010 by Noubar Afeyan, a Lebanese-born bioengineer running a biotech-venture firm called Flagship Pioneering. He recruited Stéphane Bancel, a Harvard Business School ...

ENTRETIEN - Pour le PDG de Moderna, l’intelligence artificielle va transformer l’ensemble du parcours du soin de la prévention à la mise au point des médicaments. La biotech américaine prévoit d’en ...

The Horizon programme contains a variety of mRNA assets in varying stages of development, including a preclinical in vivo candidate.

Provides broad overview of Company's research and early development programs expected to continue to fuel future growthHighlights validation of T-cell engager modality with mRNA-2808 in multiple myelo ...

CEO Stéphane Bancel reported that 2025 revenues were $1.9 billion, primarily from COVID vaccine sales, and highlighted a $2.2 billion reduction in operating expenses, stating "I would like to thank ...

Former Biogen Chief Financial Officer brings more than 35 years of financial leadership and public company experience ...

Former Biogen Chief Financial Officer brings more than 35 years of financial leadership and public company experience CAMBRIDGE, MA / ACCESS Newswire / July 8, 2026 / Moderna, Inc. (NASDAQ:MRNA) today ...

Biotech company Moderna said Thursday it plans to cut 10% of its global workforce and expects to have fewer than 5,000 employees by the end of the year. The move is part of the company's ongoing ...

MRNA Insider Trading News PRO Moderna CEO Stephane Bancel Discloses Open Market Purchase Of 160,314 Shares At Avg. Price $31.22 Benzinga Newsdesk ...

A suspect has been identified in the investigation into a parcel bombing that seriously wounded a sanctioned Ukraine-born multi-millionaire and two others in Monaco, the principality's prosecutor's ...

A makeshift bomb which detonated outside a residential building in Monaco has injured three people, with reports suggesting a Ukrainian tycoon is among them. Police have launched a manhunt to find the ...